文献速递炎症性肠病

D型人格与炎症性肠病抑郁症状及临床活动度的关联

Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2021-05-11

该研究基于瑞士IBD队列2275例患者,评估D型人格患病率及其与疾病病程的关联。结果显示29.5%患者存在D型人格,D型人格是未来疾病活动的显著危险因素(aHR 1.60),并预测抑郁症状出现(aHR 3.30);D型人格合并抑郁症状时疾病活动风险进一步升高(aHR 3.98)。

要点

  • IBD患者中D型人格患病率为29.5%,与一般人群相当。
  • D型人格是未来疾病活动的独立危险因素(aHR 1.60)。
  • D型人格合并抑郁症状时疾病活动风险显著增高(aHR 3.98)。

核心结论

  • D型人格在IBD患者中患病率与一般人群相当,与抑郁症状强烈相关,并与IBD预后存在 modest 独立关联。

研究设计与样本

  • 基于瑞士IBD队列2275例患者(1005例溃疡性结肠炎,1270例克罗恩病)的队列研究,使用D型人格量表-14评估D型人格,医院焦虑抑郁量表抑郁亚评分≥11定义抑郁症状,构建横断面回归模型和Cox比例风险模型进行时间-事件分析。

主要发现

  • 2275例患者中672例(29.5%)存在D型人格。
  • D型人格是未来疾病活动的显著危险因素(aHR 1.60,校正P值 q=0.007)。
  • D型人格预测未来抑郁症状的存在(aHR 3.30,P<0.001)。
  • D型人格合并抑郁症状进一步增加疾病活动风险(aHR 3.98,q<0.001)。
  • 校正抑郁症状后D型人格的预测能力显著下降(aHR 1.32,CI 0.97-1.79,q=0.292)。

关键数值与推荐

  • D型人格评估采用D型人格量表-14。
  • 抑郁症状定义采用医院焦虑抑郁量表抑郁亚评分≥11。
  • 疾病活动定义:克罗恩病活动指数≥150或改良Truelove & Witts活动指数≥10。

临床怎么用

  • 在IBD患者中可考虑评估D型人格和抑郁症状,以识别疾病活动风险较高的患者。
  • D型人格相关抑郁症状可能是影响疾病活动的主要因素,针对抑郁症状的干预可能有助于改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel disease (IBD) can be exacerbated by stress and depression. Type D personality, characterised by high negative affectivity and social inhibition, represents a vulnerability towards stressors and is associated with adverse outcomes in coronary heart disease. AIMS: To assess the prevalence of Type D personality in IBD patients and investigate potential associations with disease course. METHODS: We tested for associations between Type D (Type D Scale-14), depressive symptoms (Hospital Anxiety and Depression Scale's depression subscore ≥11) and recurrent IBD amongst Swiss IBD cohort patients. We built regression models for cross-sectional and Cox proportional hazards models for time-to-event analyses. IBD disease course was assessed by the future occurrence of active disease (Crohn's Disease Activity Index ≥150/Modified Truelove & Witts activity index ≥10) and several IBD-relevant endpoints. RESULTS: Amongst 2275 patients (1005 ulcerative colitis, 1270 Crohn's disease), 672 (29.5%) had Type D. Type D was a significant risk factor for future active disease (adjusted hazard ratio, aHR: 1.60, corrected P value, q = 0.007) and predicted the future presence of depressive symptoms (aHR: 3.30, P < 0.001). The combination of Type D and depressive symptoms further increased the risk for active disease (aHR: 3.98, q < 0.001). However, Type D associated depressive symptoms seemed to be the main contributor to this effect as Type D's predictive power decreased considerably in models corrected for depressive symptoms (aHR: 1.32, CI: 0.97-1.79, q = 0.292). CONCLUSIONS: Type D personality's prevalence amongst IBD patients was comparable with its prevalence in the general population. Type D was strongly associated with depressive symptoms and showed modest independent associations with IBD prognosis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Jordi SBU, Botte F, Lang BM, et al. Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease. Aliment Pharmacol Ther. 2021. PMID: 33975385. doi:10.1111/apt.16365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。